Literature DB >> 28775709

[18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia.

Yves Dauvilliers1,2, Elisa Evangelista1,2, Delphine de Verbizier3, Lucie Barateau1,2, Philippe Peigneux4.   

Abstract

BACKGROUND: Changes in structural and functional central nervous system have been reported in narcolepsy, with large discrepancies between studies. No study has investigated yet spontaneous brain activity at wake in idiopathic hypersomnia (IH). We compared relative changes in regional brain metabolism in two central hypersomnia conditions with different clinical features, namely narcolepsy type 1 (NT1) and IH, and in healthy controls.
METHODS: Sixteen patients [12 males, median age 30 years (17-78)] with NT1, nine patients [2 males, median age 27 years (20-60)] with IH and 19 healthy controls [16 males, median age 36 years (17-78)] were included. 18F-fludeoxyglucose positron emission tomography (PET) was performed in all drug-free subjects under similar conditions and instructions to stay in a wake resting state.
RESULTS: We found increased metabolism in the anterior and middle cingulate and the insula in the two pathological conditions as compared to healthy controls. The reverse contrast failed to evidence hypometabolism in patients vs. controls. Comparisons between patient groups were non-significant. At sub-statistical threshold, we found higher right superior occipital gyrus glucose metabolism in narcolepsy and higher middle orbital cortex and supplementary motor area metabolism in IH, findings that require further confirmation.
CONCLUSION: There is significant hypermetabolism in narcolepsy and IH in the wake resting state in a set of brain regions constitutive of the salience cortical network that may reflect a compensatory neurocircuitry activity secondary to sleepiness. Metabolic differences between the two disorders within the executive-control network may be a signature of abnormally functioning neural system leading to persistent drowsiness typical of IH.

Entities:  

Keywords:  default mode network; executive-control network; idiopathic hypersomnia; imaging; metabolism; narcolepsy; positron emission tomography; salience network

Year:  2017        PMID: 28775709      PMCID: PMC5517406          DOI: 10.3389/fneur.2017.00350

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  36 in total

1.  Increased brain activation during verbal learning in obstructive sleep apnea.

Authors:  Liat Ayalon; Sonia Ancoli-Israel; Zoe Klemfuss; Mark D Shalauta; Sean P A Drummond
Journal:  Neuroimage       Date:  2006-04-19       Impact factor: 6.556

2.  Baseline brain activity fluctuations predict somatosensory perception in humans.

Authors:  M Boly; E Balteau; C Schnakers; C Degueldre; G Moonen; A Luxen; C Phillips; P Peigneux; P Maquet; S Laureys
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-06       Impact factor: 11.205

Review 3.  Functional neuroimaging insights into the physiology of human sleep.

Authors:  Thien Thanh Dang-Vu; Manuel Schabus; Martin Desseilles; Virginie Sterpenich; Maxime Bonjean; Pierre Maquet
Journal:  Sleep       Date:  2010-12       Impact factor: 5.849

4.  Cerebral perfusion abnormality in narcolepsy with cataplexy.

Authors:  Eun Yeon Joo; Seung Bong Hong; Woo Suk Tae; Jee Hyun Kim; Sun Jung Han; Yong Won Cho; Chang Ho Yoon; Sung Ik Lee; Mann Hyung Lee; Kyung Han Lee; Myoung-Hee Kim; Byung Tae Kim; Leen Kim
Journal:  Neuroimage       Date:  2005-08-10       Impact factor: 6.556

Review 5.  Treatment Options for Narcolepsy.

Authors:  Lucie Barateau; Régis Lopez; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

6.  Electroencephalographic sleep inertia of the awakening brain.

Authors:  C Marzano; M Ferrara; F Moroni; L De Gennaro
Journal:  Neuroscience       Date:  2010-12-15       Impact factor: 3.590

7.  A brain PET study in patients with narcolepsy-cataplexy.

Authors:  Yves Dauvilliers; Frederic Comte; Sophie Bayard; Bertrand Carlander; Michel Zanca; Jacques Touchon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-10-22       Impact factor: 10.154

8.  Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience.

Authors:  Lynn Marie Trotti; Prabhjyot Saini; Amanda A Freeman; Donald L Bliwise; Paul S García; Andrew Jenkins; David B Rye
Journal:  J Psychopharmacol       Date:  2013-12-03       Impact factor: 4.153

9.  Large-Scale Brain Network Coupling Predicts Total Sleep Deprivation Effects on Cognitive Capacity.

Authors:  Yu Lei; Yongcong Shao; Lubin Wang; Tianye Zhai; Feng Zou; Enmao Ye; Xiao Jin; Wuju Li; Jianlin Qi; Zheng Yang
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

10.  Widespread hypermetabolism in symptomatic and asymptomatic episodes in Kleine-Levin syndrome.

Authors:  Yves Dauvilliers; Sophie Bayard; Régis Lopez; Frederic Comte; Michel Zanca; Philippe Peigneux
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

View more
  8 in total

Review 1.  The neurophysiological basis of excessive daytime sleepiness: suggestions of an altered state of consciousness.

Authors:  P K Hitchcott; D Menicucci; S Frumento; A Zaccaro; A Gemignani
Journal:  Sleep Breath       Date:  2019-05-28       Impact factor: 2.816

2.  Beyond sleepy: structural and functional changes of the default-mode network in idiopathic hypersomnia.

Authors:  Florence B Pomares; Soufiane Boucetta; Francis Lachapelle; Jason Steffener; Jacques Montplaisir; Jungho Cha; Hosung Kim; Thien Thanh Dang-Vu
Journal:  Sleep       Date:  2019-10-21       Impact factor: 5.849

Review 3.  Idiopathic Hypersomnia: Historical Account, Critical Review of Current Tests and Criteria, Diagnostic Evaluation in the Absence of Biological Markers and Robust Electrophysiological Diagnostic Criteria.

Authors:  Michel Billiard; Karel Sonka
Journal:  Nat Sci Sleep       Date:  2022-02-26

4.  Disease symptomatology and response to treatment in people with idiopathic hypersomnia: initial data from the Hypersomnia Foundation registry.

Authors:  Lynn Marie Trotti; Jason C Ong; David T Plante; Catherine Friederich Murray; Rebecca King; Donald L Bliwise
Journal:  Sleep Med       Date:  2020-09-02       Impact factor: 3.492

5.  Is Idiopathic Hypersomnia a Circadian Rhythm Disorder?

Authors:  David Landzberg; Lynn Marie Trotti
Journal:  Curr Sleep Med Rep       Date:  2019-11-25

6.  Regional brain metabolism differs between narcolepsy type 1 and idiopathic hypersomnia.

Authors:  Lynn Marie Trotti; Prabhjyot Saini; Bruce Crosson; Carolyn C Meltzer; David B Rye; Jonathon A Nye
Journal:  Sleep       Date:  2021-08-13       Impact factor: 5.849

7.  Cortico-Amygdala-Striatal Activation by Modafinil/Flecainide Combination.

Authors:  Dominique Vodovar; Adeline Duchêne; Catriona Wimberley; Claire Leroy; Géraldine Pottier; Yves Dauvilliers; Christian Giaume; Jian-Sheng Lin; Franck Mouthon; Nicolas Tournier; Mathieu Charvériat
Journal:  Int J Neuropsychopharmacol       Date:  2018-07-01       Impact factor: 5.176

8.  Recursive Partitioning Analysis of Fractional Low-Frequency Fluctuations in Narcolepsy With Cataplexy.

Authors:  Xiao Fulong; Lu Chao; Zhao Dianjiang; Zou Qihong; Zhang Wei; Zhang Jun; Han Fang
Journal:  Front Neurol       Date:  2018-11-02       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.